May 3, 2024 07:00 AM EDTUpdated 10:19 AM

Lonnel Coats announces retirement from Lexicon; Another shakeup in Vir's C-suite

Alex Hoffman

Senior Editor

Kathy Wong

Editor

→ Lexicon Pharmaceuticals CEO Lonnel Coats will retire July 7, 10 years to the day after accepting the job. Lexicon overcame numerous regulatory obstacles with …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Lonnel Coats announces retirement from Lexicon; Another shakeup in Vir's C-suite

Alex Hoffman

Senior Editor

Kathy Wong

Editor

Sign up to read this article for free.

Among pharma CEOs, the IRA now and the IRA later get very different reactions

Bristol Myers restarts radiopharmaceutical Phase 3 trial, but delays readout by one year

Updated: With cost-cutting underway, Bristol Myers raises guidance, touts Phase 3 win and scraps another

Andrew Left, short seller who campaigned against Valeant, is accused of fraud by SEC

European drug regulator rejects Alzheimer's drug Leqembi, citing safety concerns

Critical Junctures in Gene Therapy Clinical Material Manufacturing: Where Do I Start? And Will It Work?

Lon­nel Coats an­nounces re­tire­ment from Lex­i­con; An­oth­er shake­up in Vir's C-suite

Senior Editor

Editor

Sign up to read this article for free.

Lonnel Coats announces retirement from Lexicon; Another shakeup in Vir's C-suite